Explores lignocellulose degradation in CDGs, suggesting Ganoderma sp. as a viable bioconversion tool.
Chinese distillers’ grains (CDGs) are a lignocellulose-rich agricultural byproduct with considerable bioconversion potential; however, their recalcitrant structure imposes a major bottleneck for efficient valorization. In this study, six white-rot fungal strains and two Trichoderma strains were isolated from wild macrofungi, among which Ganoderma sp. 2G1-6 exhibited the highest laccase activity, reaching 11.29 U/mL. Whole-genome sequencing revealed a 49.15 Mb genome containing 12,437 predicted proteins, including a substantial repertoire of 196 glycoside hydrolases and 113 auxiliary activity enzymes implicated in lignocellulose degradation. Solid-state fermentation of CDGs with Ganoderma sp. 2G1-6 produced high enzyme activities, including endoglucanase (13.3 ± 4.6 U/g), xylanase (538.8 ± 33.0 U/g), β-glucosidase (26,572 ± 2996 U/g), and laccase (231.2 ± 16.7 U/g). Concomitantly, the nutritional profile of CDGs was markedly improved after 30 days, with crude protein increasing by 28.51%, acid-soluble protein by 33.33%, and soluble dietary fiber by 159%. Complementary structural analyses (FTIR, SEM, XRD, and TGA) confirmed progressive disruption of the lignocellulosic matrix, selective delignification, and enhanced cellulose exposure. These findings establish Ganoderma sp. 2G1-6 as a promising microbial chassis for CDGs valorization and provide preliminary functional profiles of Ganoderma species for lignocellulose bioconversion.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: